132 related articles for article (PubMed ID: 21870770)
1. [Effect of mexidol on combined vascular pathology of brain and heart].
Gnezdilova AV; Lebedeva MA; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(6):20-3. PubMed ID: 21870770
[TBL] [Abstract][Full Text] [Related]
2. [Cerebrovascular effects of afobazole under conditions of combined disorders of cerebral and coronary circulation].
Mirzoian RS; Khaĭlov NA; Gan'shina TS
Eksp Klin Farmakol; 2010 May; 73(5):2-7. PubMed ID: 20597361
[TBL] [Abstract][Full Text] [Related]
3. [Cerebrovascular pharmacology of separate and combined vascular pathology of brain and heart].
Mirzoian RS; Gan'shina TS; Khaĭlov NA; Gnezdilova AV; Maslennikov DV; Kurdiumov IN; Lebedeva MA; Gorbunov AA
Eksp Klin Farmakol; 2014; 77(3):3-8. PubMed ID: 24800517
[TBL] [Abstract][Full Text] [Related]
4. [Nimodipine and experimental combined disorders of cerebral and coronary circulation].
Mirzoian RS; Khaĭlov NA; Tsorin IB; Gan'shina TS
Eksp Klin Farmakol; 2009; 72(2):24-8. PubMed ID: 19441723
[TBL] [Abstract][Full Text] [Related]
5. [Cerebrovascular and antiserotoninergic activity of the combination of tropoxin and mexidol].
Gorbunov AA; Gan'shina TS; Turilova AI; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):23-7. PubMed ID: 22232910
[TBL] [Abstract][Full Text] [Related]
6. [Influence of 2-ethyl-6-methyl-3-hydroxypyridine hemisuccinate on cerebral blood perfusion in rats under experimental pathology conditions].
Gan'shina TS; Gorbunov AA; Gnezdilova AV; Kurdiumov IN; Avdiunina NI; Piatin BM; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):17-22. PubMed ID: 22232909
[TBL] [Abstract][Full Text] [Related]
7. [Cerebrovascular effects of GABA conjugate with arachidonic acid under conditions of separate and combined vascular pathology of brain and heart].
Gnezdilova AV; Gan'shina TS; Maslennikov DV; Bezuglov VV; Gretskaia NM; Mirzoian RS
Eksp Klin Farmakol; 2011; 74(8):28-31. PubMed ID: 22232911
[TBL] [Abstract][Full Text] [Related]
8. [GABAergic mechanism of cerebrovasculareffect of mexidol].
gnezdilova AV; Gan'shina TS; Mirzoian RS
Eksp Klin Farmakol; 2010 Oct; 73(10):11-3. PubMed ID: 21254506
[TBL] [Abstract][Full Text] [Related]
9. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats.
Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R
Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594
[TBL] [Abstract][Full Text] [Related]
10. A small animal model of focal cerebral ischemia for studying neuroprotective agents.
Holland JP; Bell BA
Ann N Y Acad Sci; 1995 Sep; 765():301-2. PubMed ID: 7486618
[No Abstract] [Full Text] [Related]
11. [Peculiarities of cerebrovascular effects of GABA conjugate with docosahexaenoyl dopamine under conditions of separate and combined vascular pathology of brain and heart].
Mirzoian RS; Gan'shina TS; Khaĭlov NA; Kurdiumov IN; Lebedeva MA; Gretskaia NM; Bezuglov VV
Eksp Klin Farmakol; 2012; 75(7):15-9. PubMed ID: 23025047
[TBL] [Abstract][Full Text] [Related]
12. [Effect of ketamine on cerebral circulation of intact and ischemic animals].
Melkumian VS; Khaĭlov NA; Gaevyĭ MD
Eksp Klin Farmakol; 2004; 67(1):15-8. PubMed ID: 15079901
[TBL] [Abstract][Full Text] [Related]
13. Regional cerebral blood flow autoregulation in a silicone embolus model of focal brain ischemia as assessed by multichannel laser Doppler flowmetry.
Lauer KK; Shen H; Hudetz AG; Stein EA; Kampine JP
Adv Exp Med Biol; 1998; 454():253-9. PubMed ID: 9889899
[No Abstract] [Full Text] [Related]
14. [Adamantane derivate enhances cerebral blood flow under conditions of ischemic brain damage].
Mirzoian RS; Gan'shina TS; Maslennikov DV; Turilova AI; Avdiunina NI; Piatin BM
Eksp Klin Farmakol; 2012; 75(6):27-30. PubMed ID: 22891438
[TBL] [Abstract][Full Text] [Related]
15. [The anti-ischemic effects of 3-hydroxypyridine derivatives in cerebrovascular pathology].
Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Gatsura VV; Smirnov LD
Eksp Klin Farmakol; 1999; 62(5):15-7. PubMed ID: 10572744
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
Zausinger S; Westermaier T; Plesnila N; Steiger HJ; Schmid-Elsaesser R
Stroke; 2003 Jun; 34(6):1526-32. PubMed ID: 12730554
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats.
Ellsworth JL; Garcia R; Yu J; Kindy MS
Stroke; 2003 Jun; 34(6):1507-12. PubMed ID: 12738892
[TBL] [Abstract][Full Text] [Related]
18. Role of residual flow on the neuroprotective efficacy of human albumin in the rat with transient cerebral ischemia.
Chen J; Ji X; Ding Y; Luo Y; Cheng H; Ling F
Neurol Res; 2009 May; 31(4):396-401. PubMed ID: 19508826
[TBL] [Abstract][Full Text] [Related]
19. [Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone].
Lun'shina EV; Gan'shina TS; Makarova LM; Pogorelyĭ VE; Mirzoian RS
Eksp Klin Farmakol; 2003; 66(1):20-2. PubMed ID: 12683075
[TBL] [Abstract][Full Text] [Related]
20. Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats.
Lee EJ; Chen HY; Wu TS; Chen TY; Ayoub IA; Maynard KI
J Neurosci Res; 2002 Jun; 68(5):636-45. PubMed ID: 12111854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
